Evidence map›Paper›PMID 36271327›Full record

ArticleBMC microbiology2022

Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran.

Raana Kazemzadeh Anari, Farhad Nikkhahi, Amir Javadi, Mehdi Bakht, Mohammad Rostamani, Fatemeh Zeynali Kelishomi, Safar Ali Alizadeh

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Insights into antibiotic resistance and prevalence ofNew microbes and new infections · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Metabolic Changes inMetabolites · 2024
    Article
  9. The Mla system and its role in maintaining outer membrane barrier function inFrontiers in cellular and infection microbiology · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raana Kazemzadeh AnariMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Farhad NikkhahiMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Amir JavadiMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi BakhtMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mohammad RostamaniMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Fatemeh Zeynali KelishomiMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Safar Ali AlizadehMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran. alizadeh120@yahoo.com.
Qazvin University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe overuse of biocides in healthcare-facilities poses risk for emergence and spread of antibiotic resistance among nosocomial pathogens. Hospital-acquired infections due to S. maltophilia have been increased in the recent years and with its various resistance mechanisms contribute to patient morbidity and mortality in hospitals. The current study aimed to evaluate the susceptibility of biofilm-producing and non-producing S. maltophilia clinical isolates to five commonly used hospital biocides, alone and in combination with EDTA to examine the synergistic effect of combining EDTA on the bactericidal activity of them by microbroth dilution method. As well as the frequency of efflux genes encoding resistance to biocides among isolates. This study also intended to assess the effect of exposure of S. maltophilia isolates to sub-inhibitory concentrations of sodium hypochlorite upon the antimicrobial susceptibility patterns.

resultsBased on minimum inhibitory and bactericidal concentrations of biocides sodium hypochlorite 5% (w/v) and ethyl alcohol 70% (v/v) were the strongest and weakest biocides against S. maltophilia isolates, respectively. The combination of EDTA with biocides significantly increased the effectiveness of the studied biocides. Exposure to sub-inhibitory concentration of sodium hypochlorite showed a significant change in the susceptibility of isolates towards ceftazidime (p = 0.019), ticarcillin/clavulanate (p = 0.009), and chloramphenicol (p = 0.028). As well as among the isolates examined, 94 (95%) were able to produce biofilm. The frequency of sugE1 resistance genes was found in 90.7% of our clinical S. maltophilia isolates. None of the isolates carried qacE and qacEΔ1 gene.

conclusionsThe current study recommended that using the mixture of biocides with EDTA can be effective in reducing nosocomial infections. Also, this study demonstrated that exposure to sub-inhibitory concentrations of sodium hypochlorite leads to reduced antibiotic susceptibility and development of multidrug-resistant S. maltophilia strains.

Indexed as

Cross InfectionDisinfectantsGram-Negative Bacterial InfectionsStenotrophomonas maltophiliaAnti-Bacterial AgentsBiofilmsCeftazidimeChloramphenicolClavulanic AcidEdetic AcidEthanolHumansIranMicrobial Sensitivity TestsSodium HypochloriteTicarcillinAnti-Bacterial AgentsCeftazidimeChloramphenicolClavulanic AcidDisinfectantsEdetic AcidEthanolSodium HypochloriteTicarcillinAntibiotic resistanceBiocide-resistanceBiofilmNosocomial infectionStenotrophomonas maltophilia

Identifiers

PMID36271327
PMCPMC9585780
OpenAlexW4306969521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.